# Task A63: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus

> **NIH NIH N01** · UNIVERSITY OF TEXAS MED BR GALVESTON · 2024 · $849,562

## Abstract

This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.

## Key facts

- **NIH application ID:** 11042000
- **Project number:** 272201700040I-P00004-759302200001-1
- **Recipient organization:** UNIVERSITY OF TEXAS MED BR GALVESTON
- **Principal Investigator:** DAVID BEASLEY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $849,562
- **Award type:** —
- **Project period:** 2021-11-04 → 2024-11-03

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11042000

## Citation

> US National Institutes of Health, RePORTER application 11042000, Task A63: Evaluation of Therapeutics and Vaccines in Mouse Models of Dengue Virus (272201700040I-P00004-759302200001-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/11042000. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*